Prediction of non-small cell lung cancer subtypes is possible through restricted spectrum imaging.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
97 patients with NSCLC (30 with squamous cell carcinoma (SCC) and 67 with adenocarcinoma (AC)) were included.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Calibration curves and DCA confirmed the model's stability and clinical utility. [CONCLUSION] RSI can effectively differentiate NSCLC subtypes.
[BACKGROUND] To evaluate the utility of restricted spectrum imaging (RSI) for predicting subtypes of non-small cell lung cancer (NSCLC).
- p-value P < 0.05
- p-value P < 0.01
- Sensitivity 73.33%
- Specificity 89.55%
APA
Shen L, Zhang Y, et al. (2025). Prediction of non-small cell lung cancer subtypes is possible through restricted spectrum imaging.. Frontiers in oncology, 15, 1737182. https://doi.org/10.3389/fonc.2025.1737182
MLA
Shen L, et al.. "Prediction of non-small cell lung cancer subtypes is possible through restricted spectrum imaging.." Frontiers in oncology, vol. 15, 2025, pp. 1737182.
PMID
41635406 ↗
Abstract 한글 요약
[BACKGROUND] To evaluate the utility of restricted spectrum imaging (RSI) for predicting subtypes of non-small cell lung cancer (NSCLC).
[METHODS] A total of 97 patients with NSCLC (30 with squamous cell carcinoma (SCC) and 67 with adenocarcinoma (AC)) were included. The parameters f, f, f, apparent diffusion coefficient (ADC), and maximum standardized uptake value (SUV) were measured and compared between the two subtypes. Logistic regression analysis was used to identify independent predictors, and a combined diagnostic model was developed. The performance of the model was assessed using receiver operating characteristic (ROC) curve analysis, calibration curves, and decision curve analysis (DCA).
[RESULTS] Compared with the AC group, the SCC group exhibited significantly higher SUV, f, and f values, and lower ADC and f values (all P < 0.05). Smoking status, f, SUV, and ADC were independent predictors of NSCLC subtypes. The combined model demonstrated superior diagnostic accuracy (AUC = 0.909; sensitivity = 73.33%; specificity = 89.55%) compared with individual predictors (AUC = 0.693, 0.819, 0.767, and 0.742 for smoking status, f, SUV, and ADC, respectively; all P < 0.01). Bootstrap resampling (1000 samples) validated the robustness of the model (AUC = 0.895). Calibration curves and DCA confirmed the model's stability and clinical utility.
[CONCLUSION] RSI can effectively differentiate NSCLC subtypes.
[METHODS] A total of 97 patients with NSCLC (30 with squamous cell carcinoma (SCC) and 67 with adenocarcinoma (AC)) were included. The parameters f, f, f, apparent diffusion coefficient (ADC), and maximum standardized uptake value (SUV) were measured and compared between the two subtypes. Logistic regression analysis was used to identify independent predictors, and a combined diagnostic model was developed. The performance of the model was assessed using receiver operating characteristic (ROC) curve analysis, calibration curves, and decision curve analysis (DCA).
[RESULTS] Compared with the AC group, the SCC group exhibited significantly higher SUV, f, and f values, and lower ADC and f values (all P < 0.05). Smoking status, f, SUV, and ADC were independent predictors of NSCLC subtypes. The combined model demonstrated superior diagnostic accuracy (AUC = 0.909; sensitivity = 73.33%; specificity = 89.55%) compared with individual predictors (AUC = 0.693, 0.819, 0.767, and 0.742 for smoking status, f, SUV, and ADC, respectively; all P < 0.01). Bootstrap resampling (1000 samples) validated the robustness of the model (AUC = 0.895). Calibration curves and DCA confirmed the model's stability and clinical utility.
[CONCLUSION] RSI can effectively differentiate NSCLC subtypes.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Functional roles, mechanistic insights, and therapeutic potential of the IGF2BP family in viral infections and virus-associated cancers.
- Clinical efficacy of comprehensive traditional Chinese medicine in adjuvant therapy for stage Ib-IIIa resected non-small cell lung cancer: a multi-center, randomized, double-blind, placebo-controlled trial.
- Clinical and structural insights into concurrent EGFR and MET exon 14 skipping mutations in NSCLC: a multi-center series.
- Tumour-associated macrophages serve as an acetate reservoir to drive hepatocellular carcinoma metastasis.
- Enhanced Image Quality and Comparable Diagnostic Performance of Prostate Fast Bi-MRI with Deep Learning Reconstruction.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Association of immune-related adverse events with survival in patients receiving immune checkpoint inhibitor plus chemotherapy for lung cancer.
- DIP-like Adenocarcinoma Presenting as a Part-Solid Nodule: A Case Report.
- NRF2 pathway activation predicts poor prognosis in lung cancer: a cautionary note on antioxidant interventions.
- Dynamic fluorine-18 fluorodeoxyglucose PET for evaluating different-sized metastatic lymph nodes in patients with non-small cell lung cancers.
- The role of multimodality imaging in selection, response assessment, and follow-up of patients receiving Lutetium-PSMA-therapy.
- Impact of race/ethnicity and the presence of immune-related adverse events on outcomes for non-small cell lung cancer patients treated with immune checkpoint inhibitors.